PILOTTO, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 222
EU - Europa 155
AS - Asia 93
OC - Oceania 1
Totale 471
Nazione #
US - Stati Uniti d'America 222
CN - Cina 91
IE - Irlanda 85
FI - Finlandia 21
IT - Italia 17
DE - Germania 12
UA - Ucraina 10
BE - Belgio 5
GB - Regno Unito 2
GR - Grecia 2
AT - Austria 1
AU - Australia 1
IL - Israele 1
IN - India 1
Totale 471
Città #
Dublin 85
Chandler 52
Beijing 25
Nanjing 23
Jacksonville 21
Ann Arbor 16
Ashburn 14
New York 12
Helsinki 11
Medford 11
Princeton 11
Lawrence 10
Shenyang 9
Jiaxing 8
Pavia 8
Wilmington 7
Changsha 6
Brussels 5
Hebei 4
Nanchang 4
Shanghai 4
Woodbridge 3
Boardman 2
Fairfield 2
Hangzhou 2
Los Angeles 2
Redwood City 2
San Mateo 2
Tianjin 2
Varenna 2
Brescia 1
Cambridge 1
Falkenstein 1
Fremont 1
Fuzhou 1
Haifa 1
Jinan 1
Lanzhou 1
Melbourne 1
Monmouth Junction 1
Nave 1
Norwalk 1
Pune 1
Redmond 1
Sassari 1
Vienna 1
Washington 1
Zhengzhou 1
Totale 383
Nome #
Interplay among nucleosomal DNA, histone tails, and corepressor CoREST underlies LSD1-mediated H3 demethylation. 83
Polymyxins and quinazolines are LSD1/KDM1A inhibitors with unusual structural features 56
Protein Recognition by Short Peptide Reversible Inhibitors of the Chromatin-Modifying LSD1/CoREST Lysine Demethylase. 54
A Tail-Based Mechanism Drives Nucleosome Demethylation by the LSD2/NPAC Multimeric Complex 50
Touch, act and go: Landing and operating on nucleosomes 44
LSD1/KDM1A mutations associated to a newly described form of intellectual disability impair demethylase activity and binding to transcription factors 43
Nutritional support in lung cancer: Time to combine immunonutrition with immunotherapy? 40
Impact of Mutations on NPAC Structural Dynamics: Mechanistic Insights from MD Simulations 37
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis 33
Phosphorylation of neuronal Lysine-Specific Demethylase 1LSD1/KDM1A impairs transcriptional repression by regulating interaction with CoREST and histone deacetylases HDAC1/2. 31
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 30
Totale 501
Categoria #
all - tutte 2.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/2020110 28 33 0 2 3 4 8 3 0 9 19 1
2020/202140 3 2 0 3 0 3 3 12 4 7 3 0
2021/202253 1 1 0 2 1 0 1 3 1 1 14 28
2022/2023170 19 23 1 13 7 10 0 3 92 1 0 1
2023/202477 21 17 1 3 2 25 3 0 3 2 0 0
Totale 501